FierceBiotech

Xilis nets $70M to build out organoid-generating platform for cancer treatment, drug development

Though the central premise of cancer treatment is to eliminate any and all evidence of a tumor, Xilis’ approach begins by creating thousands of more replicas of a patient’s cancer cells to inform the ...
Mena FN

Xilis Announces Formation Of Its Scientific Advisory Board'

xilis , a pioneering biotech company advancing its proprietary MicroOrganoSphereTM (MOS) Platform to accelerate drug discovery and development and advance functional precision medicine for cancer ...
Business Wire

Xilis Raises $70 Million Series A Financing to Advance Diagnostic and Drug Discovery and Development Platform Leveraging Proprietary MicroOrganoSphere™ Technology

DURHAM, N.C.--(BUSINESS WIRE)--Xilis, Inc., a pioneering company using its MicroOrganoSphere (MOS) technology to guide precision therapy for cancer patients and accelerate drug discovery and ...
Business Wire

Xilis Announces Series A Extension, Bringing Total Round to Over US$89 Million

DURHAM, N.C.--(BUSINESS WIRE)--Xilis, Inc., a pioneering biotechnology company developing its MicroOrganoSphere™ (MOS™) technology to guide precision therapy for cancer patients and accelerate drug ...
WRAL TechWire

Durham biotech startup Xilis raises $19M for precision cancer therapy, drug discovery

DURHAM – Biotech startup Xilis has added another $19 million to its round of financing, pushing the total to $89 million from the $70 million announced a year ago. The company is focusing on ways to ...